Factory Making Illegal Oxytocin Injections Busted In Delhi, Owner Arrested

New Delhi: After the directives from the Delhi High Court to combat the use of spurious oxytocin in dairy colonies across the national capital recently, the city police and the Drug Control Department conducted a joint raid, busting an illegal manufacturing unit and arresting its owner, an official said on Sunday.

The accused was identified as Praveen Kumar, who indulged in the illegal manufacturing of veterinary oxytocin injections for the past six months without the requisite license.

“The premises were found stocked with various materials used in the manufacturing process, including empty plastic bottles, crimp caps, sealing machines, and raw materials for oxytocin preparation,” the official added.

The oxytocin veterinary injection is a restricted drug indicated for obstetrical use in cows, sheep, and horses. However, it is widely misused in milch animals to increase milk production, especially in dairies.

According to the Delhi government’s Drug Control Department, on Saturday, acting on the intelligence provided by the Station House Officer (SHO), Bhalswa Dairy police station, was tipped off about illegal manufacturing activities concerning oxytocin.

“A joint team of the Drug Control Department and the Delhi Police conducted a raid at the premises in Swaroop Nagar area and uncovered a clandestine operation of manufacturing oxytocin veterinary injection by the accused Praveen Kumar,” said a senior Drug Control Department official.

The accused also failed to produce any valid drug license or purchase records for the materials used in manufacturing.

“He (the accused) used to manufacture this preparation from a concentrated solution and manually fill in plastic bottles after dilution. These plastic bottles used to be manually sealed with the help of a crimping machine. It was also revealed that the illegal oxytocin was being supplied to various dairy farms without proper documentation. He used to get this oxytocin-concentrated solution from Ghaziabad in Uttar Pradesh as disclosed by him,” the official added.

In the course of the operation, samples of the illicitly manufactured oxytocin were collected for further testing/analysis as per the Drugs and Cosmetics Act,1940.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre